Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial

Reliever inhaler overuse and delay in medical review in asthma In asthma, overuse of beta-agonist reliever medication and delay in seeking medical review in an exacerbation are linked to asthma deaths. Janine Pilcher at the Medical Research Institute of New Zealand, and co-workers, conducted a revie...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Janine Pilcher, Mitesh Patel, Alison Pritchard, Darmiga Thayabaran, Stefan Ebmeier, Dominick Shaw, Peter Black, Irene Braithwaite, Mark Weatherall, Richard Beasley
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/c61a595ab85b4f22a0bae3704b80e50f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c61a595ab85b4f22a0bae3704b80e50f
record_format	dspace
spelling	oai:doaj.org-article:c61a595ab85b4f22a0bae3704b80e50f2021-12-02T15:18:51ZBeta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial10.1038/s41533-017-0032-z2055-1010https://doaj.org/article/c61a595ab85b4f22a0bae3704b80e50f2017-05-01T00:00:00Zhttps://doi.org/10.1038/s41533-017-0032-zhttps://doaj.org/toc/2055-1010Reliever inhaler overuse and delay in medical review in asthma In asthma, overuse of beta-agonist reliever medication and delay in seeking medical review in an exacerbation are linked to asthma deaths. Janine Pilcher at the Medical Research Institute of New Zealand, and co-workers, conducted a review of data from a study of 303 adult patients with severe asthma, followed over 24 weeks. The patients were allocated to either a budesonide/formoterol, or a salbutamol inhaler to take for symptom relief, in addition to their maintenance treatment. Inhalers were fitted with electronic monitors, to accurately document every use. In both groups, on 90% of days when an exacerbation requiring excess use of an inhaler occurred, patients did not follow-up with medical professionals within 48 h as advised. Further, in both groups, ‘extreme’ reliever inhaler use was recorded at least once in around one in four patients.Janine PilcherMitesh PatelAlison PritchardDarmiga ThayabaranStefan EbmeierDominick ShawPeter BlackIrene BraithwaiteMark WeatherallRichard BeasleyNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 27, Iss 1, Pp 1-8 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the respiratory system RC705-779
spellingShingle	Diseases of the respiratory system RC705-779 Janine Pilcher Mitesh Patel Alison Pritchard Darmiga Thayabaran Stefan Ebmeier Dominick Shaw Peter Black Irene Braithwaite Mark Weatherall Richard Beasley Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
description	Reliever inhaler overuse and delay in medical review in asthma In asthma, overuse of beta-agonist reliever medication and delay in seeking medical review in an exacerbation are linked to asthma deaths. Janine Pilcher at the Medical Research Institute of New Zealand, and co-workers, conducted a review of data from a study of 303 adult patients with severe asthma, followed over 24 weeks. The patients were allocated to either a budesonide/formoterol, or a salbutamol inhaler to take for symptom relief, in addition to their maintenance treatment. Inhalers were fitted with electronic monitors, to accurately document every use. In both groups, on 90% of days when an exacerbation requiring excess use of an inhaler occurred, patients did not follow-up with medical professionals within 48 h as advised. Further, in both groups, ‘extreme’ reliever inhaler use was recorded at least once in around one in four patients.
format	article
author	Janine Pilcher Mitesh Patel Alison Pritchard Darmiga Thayabaran Stefan Ebmeier Dominick Shaw Peter Black Irene Braithwaite Mark Weatherall Richard Beasley
author_facet	Janine Pilcher Mitesh Patel Alison Pritchard Darmiga Thayabaran Stefan Ebmeier Dominick Shaw Peter Black Irene Braithwaite Mark Weatherall Richard Beasley
author_sort	Janine Pilcher
title	Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
title_short	Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
title_full	Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
title_fullStr	Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
title_full_unstemmed	Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
title_sort	beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/c61a595ab85b4f22a0bae3704b80e50f
work_keys_str_mv	AT janinepilcher betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT miteshpatel betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT alisonpritchard betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT darmigathayabaran betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT stefanebmeier betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT dominickshaw betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT peterblack betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT irenebraithwaite betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT markweatherall betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial AT richardbeasley betaagonistoveruseanddelayinobtainingmedicalreviewinhighriskasthmaasecondaryanalysisofdatafromarandomisedcontrolledtrial
_version_	1718387473728405504

Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial

Ejemplares similares